Inventor · disambiguated record
Adrianus Q. Bakker
Also filed as: BAKKER ADRIANUS · BAKKER ADRIANUS Q · BAKKER ADRIANUS QUIRINUS
16 granted patents·2 pending applications·367 citations·filing 2003–2023
93Inventor score
Files withAIMM THERAPEUTICS BV4MEDIMMUNE LTD4BEAUMONT TIM3CRUCELL HOLLAND BV2KLING BIOTHERAPEUTICS B V2
Top patents by PatentIndex Score
18 records- 0197US8568726B2RSV specific binding moleculeBEAUMONT TIM·Filed 2010·Granted Oct 29, 2013·62 cites·9 claims
- 0296US7550140B2Antibody to the human OX40 receptorCRUCELL HOLLAND BV·Filed 2003·Granted Jun 23, 2009·173 cites·8 claims
- 0395US10035843B2RSV-specific binding moleculeMEDIMMUNE LTD·Filed 2016·Granted Jul 31, 2018·10 cites·20 claims
- 0494US8133983B2Agonistic binding molecules to the human OX40 receptorBAKKER ALEXANDER BERTHOLD HENDRIK·Filed 2009·Granted Mar 13, 2012·85 cites·13 claims
- 0593US9283274B2RSV specific binding moleculeMEDIMMUNE LTD·Filed 2013·Granted Mar 15, 2016·9 cites·34 claims
- 0689US10723786B2RSV-specific binding moleculeMEDIMMUNE LTD·Filed 2018·Granted Jul 28, 2020·3 cites·19 claims
- 0787US9206247B2Means and methods for producing high affinity antibodiesBEAUMONT TIM·Filed 2011·Granted Dec 8, 2015·7 cites·18 claims
- 0887US8642513B2Method for preparing immunoglobulin librariesTHROSBY MARK·Filed 2006·Granted Feb 4, 2014·8 cites·22 claims
- 0985US7741443B2Binding molecules for the treatment of myeloid cell malignanciesCRUCELL HOLLAND BV·Filed 2005·Granted Jun 22, 2010·7 cites·16 claims
- 1078US9273118B2Means and methods for producing high affinity antibodiesBEAUMONT TIM·Filed 2010·Granted Mar 1, 2016·2 cites·7 claims
- 1173US2023242667A1Means and methods for counteracting myeloproliferative or lymphoproliferative disordersKLING BIOTHERAPEUTICS B V·Filed 2023·Application pending·0 cites
- 1271US2021277094A9Rsv-specific binding moleculeMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1370US8268966B2Binding molecules for the treatment of myeloid cell malignanciesVAN DEN OUDENRIJN SONJA·Filed 2009·Granted Sep 18, 2012·1 cites·3 claims
- 1464US11629200B2Means and methods for counteracting myeloproliferative or lymphoproliferative disordersKLING BIOTHERAPEUTICS B V·Filed 2020·Granted Apr 18, 2023·0 cites·16 claims
- 1557US10556963B2Means and methods for counteracting myeloproliferative or lymphoproliferative disordersAIMM THERAPEUTICS BV·Filed 2014·Granted Feb 11, 2020·0 cites·16 claims
- 1655US10344076B2Means and methods for producing high affinity antibodiesAIMM THERAPEUTICS BV·Filed 2016·Granted Jul 9, 2019·0 cites·9 claims
- 1750US9969795B2Means and methods for producing high affinity antibodiesAIMM THERAPEUTICS BV·Filed 2015·Granted May 15, 2018·0 cites·8 claims
- 1835US10611829B2Means and methods for producing stable antibodiesAIMM THERAPEUTICS BV·Filed 2015·Granted Apr 7, 2020·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →